AR and prostate cancer: In addition to the key roles of androgens and AR in the regulation of prostate cancer pathogenesis, a variety of hormone-responsive GPCRs are also involved in the occurrence and development of prostate cancer, so they may serve as potential alternative drug targets for prostate cancer intervention.